Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZENITH TECHNOLOGY CORPORATION LIMITED

Home Clinical Trial Sponsors and OrganizationsZENITH TECHNOLOGY CORPORATION LIMITED

ZENITH TECHNOLOGY CORPORATION LIMITED

156 Frederick Street, Dunedin, Otago, New Zealand

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

96

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

89

92.7%

Phase 4

6

6.3%

Not Applicable

1

1.0%

Trial Status Distribution

Completed

88

91.7%

Withdrawn

8

8.3%

Clinical Trials

Trials sponsored by this organization (96)

Pivotal in vivo bioequivalence study comparing two formulations of betamethsone OV ointment applied to the skin in healthy male and female volunteers.

May 202490 participants

Pivotal in vivo bioequivalence study comparing two formulations of betamethsone ointment applied to the skin in healthy male and female volunteers.

Feb 202490 participants

Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® OV ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.

Nov 202312 participants

Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.

Nov 202312 participants

Comparative assessment of the absorption of an Iron Polymaltose tablet against an innovator product conducted in iron deficient participants under fed conditions with diet control (low iron and low fat).

Sep 202324 participants

Pivotal in vivo bioequivalence study comparing two formulations of 9-fluoro-11ß-hydroxy- 16ß-methyl-3,20-dioxopregna- 1,4-diene-17,21-diyl dipropanoate cream applied to the skin in healthy male and female volunteers.

Sep 202390 participants

Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® cream applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.

Aug 202312 participants

Pivotal in vivo bioequivalence study comparing two formulations of 21-acetoxyl group-11 beta-hydroxy-6 Alpha-Methyls-17-propiono Oxy-1,4-pregnen diethylene-3,20-diketone fatty ointment applied to the skin in healthy male and female volunteers.

May 202390 participants

Page 1 of 12

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials96
Approvals
News

Back to Organizations